de Wit-van der Veen BJ - Search Results

1

Quantification of biochemical PSA dynamics after radioligand therapy with [¹⁷⁷Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model.

Siebinga H, de Wit-van der Veen BJ, de Vries-Huizing DMV, Vogel WV, Hendrikx JJMA, Huitema ADR. Siebinga H, et al. Among authors: de wit van der veen bj. EJNMMI Phys. 2024 Apr 24;11(1):39. doi: 10.1186/s40658-024-00642-2. EJNMMI Phys. 2024. PMID: 38656678 Free PMC article.

2

Non-specific irreversible ⁸⁹Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using ⁸⁹Zr-immuno-PET.

Wijngaarden JE, Jauw YWS, Zwezerijnen GJC, de Wit-van der Veen BJ, Vugts DJ, Zijlstra JM, van Dongen GAMS, Boellaard R, Menke-van der Houven van Oordt CW, Huisman MC. Wijngaarden JE, et al. Among authors: de wit van der veen bj. EJNMMI Res. 2024 Feb 15;14(1):18. doi: 10.1186/s13550-024-01079-5. EJNMMI Res. 2024. PMID: 38358425 Free PMC article.

3

The cycle effect quantified: reduced tumour uptake in subsequent cycles of [¹⁷⁷Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy.

Siebinga H, Hendrikx JJMA, de Vries-Huizing DMV, Huitema ADR, de Wit-van der Veen BJ. Siebinga H, et al. Among authors: de wit van der veen bj. Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):820-827. doi: 10.1007/s00259-023-06463-2. Epub 2023 Oct 16. Eur J Nucl Med Mol Imaging. 2024. PMID: 37843598

4

Predicting [¹⁷⁷Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [⁶⁸Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling.

Siebinga H, de Wit-van der Veen BJ, Beijnen JH, Stokkel MPM, Dorlo TPC, Huitema ADR, Hendrikx JJMA. Siebinga H, et al. Among authors: de wit van der veen bj. EJNMMI Phys. 2023 Aug 24;10(1):48. doi: 10.1186/s40658-023-00565-4. EJNMMI Phys. 2023. PMID: 37615812 Free PMC article.

5

Predicting the effect of different folate doses on [⁶⁸Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling.

Siebinga H, Hendrikx JJMA, Huitema ADR, de Wit-van der Veen BJ. Siebinga H, et al. Among authors: de wit van der veen bj. EJNMMI Res. 2023 Jun 15;13(1):60. doi: 10.1186/s13550-023-01008-y. EJNMMI Res. 2023. PMID: 37318681 Free PMC article.

6

Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of ¹⁷⁷ Lu-PSMA-617 in prostate cancer patients.

Siebinga H, Privé BM, Peters SMB, Nagarajah J, Dorlo TPC, Huitema ADR, de Wit-van der Veen BJ, Hendrikx JJMA. Siebinga H, et al. Among authors: de wit van der veen bj. CPT Pharmacometrics Syst Pharmacol. 2023 Aug;12(8):1060-1071. doi: 10.1002/psp4.12914. Epub 2023 Feb 9. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36760133 Free PMC article.

7

A physiologically based pharmacokinetic model for [⁶⁸Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients.

Siebinga H, de Wit-van der Veen BJ, Beijnen JH, Dorlo TPC, Huitema ADR, Hendrikx JJMA. Siebinga H, et al. Among authors: de wit van der veen bj. EJNMMI Res. 2023 Feb 3;13(1):8. doi: 10.1186/s13550-023-00958-7. EJNMMI Res. 2023. PMID: 36735114 Free PMC article.

8

Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review.

Siebinga H, de Wit-van der Veen BJ, Stokkel MDM, Huitema ADR, Hendrikx JJMA. Siebinga H, et al. Among authors: de wit van der veen bj. Theranostics. 2022 Nov 14;12(18):7804-7820. doi: 10.7150/thno.77279. eCollection 2022. Theranostics. 2022. PMID: 36451855 Free PMC article. Review.

9

The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on ⁶⁸Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer.

Siebinga H, Heuvel JO, Rijkhorst EJ, Hendrikx JJMA, de Wit-van der Veen BJ. Siebinga H, et al. Among authors: de wit van der veen bj. J Nucl Med. 2023 Jan;64(1):63-68. doi: 10.2967/jnumed.122.264101. Epub 2022 Jun 9. J Nucl Med. 2023. PMID: 35680416 Free article.

10

Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy course.

de Vries-Huizing DMV, Versleijen MWJ, Sinaasappel M, Walraven I, Geluk-Jonker MM, Tesselaar MET, Hendrikx JJMA, de Wit-van der Veen BJ, Stokkel MPM. de Vries-Huizing DMV, et al. Among authors: de wit van der veen bj. PLoS One. 2021 Nov 18;16(11):e0260073. doi: 10.1371/journal.pone.0260073. eCollection 2021. PLoS One. 2021. PMID: 34793530 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page